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Objective: To investigate feasibility and acceptability of self-testing for proteinuria during pregnancy.
Study design: Mixed methods approach which included: an accuracy study where pregnant women (n=100)
and healthcare professionals (n=96) tested seven synthetic protein samples and completed a questionnaire, a
feasibility study where pregnant women who were self-monitoring their blood pressure were asked to self-test
for proteinuria (n= 30), and an online questionnaire about women’s experiences of self-testing (n=200).
Main outcome measures: Sensitivity and speciﬁcity of testing and questionnaire results.
Results: There were no signiﬁcant diﬀerences in the accuracy of synthetic sample testing by pregnant women
(sensitivity 0.81 (95% conﬁdence intervals (CI) 0.78–0.85), speciﬁcity 0.93 (95% CI 0.91–0.95)) and healthcare
professionals: (sensitivity 0.83 (95% CI 0.79–0.86), speciﬁcity 0.92 (95% CI 0.90–0.94)). Automated readers had
signiﬁcantly better sensitivity (0.94 (0.91–0.97) (p≤ .001 in each case), but worse speciﬁcity 0.78 (0.69–0.85).
Similar results were gained using self-tested urine samples compared to staﬀ-testing using a reference standard
of laboratory urine protein-creatinine ratio (uPCR). Women who completed the online survey with experience of
self-testing (n=39, 20%) generally found it easy, and with support from healthcare professionals felt it im-
proved involvement in their care and reduced anxiety.
Conclusions: Self-testing for proteinuria by pregnant women had similar accuracy to healthcare professional
testing and was acceptable to both groups. Self-testing of urine combined with self-monitoring of blood pressure
could provide a useful adjunct to clinic-based surveillance for the detection of pre-eclampsia. Such novel stra-
tegies warrant further research.
1. Introduction
Apart from blood pressure measurement, urinalysis for protein is the
most commonly performed antenatal screening test and is central to
pre-eclampsia diagnosis [1]. The development of proteinuria in a hy-
pertensive pregnancy is an important feature of multi-organ involve-
ment [2]. Urine testing is routinely carried out by midwives, ob-
stetricians or family physicians at antenatal visits [1]. Urinalysis
reagent strips (dipsticks) are widely commercially available, in-
expensive, convenient, and provide a rapid result [4]. Such testing
strips are examined with automated readers or by visual inspection, the
latter still commonplace out of hospital settings, where automated
readers are seldom available. If positive results are found, then further
testing, using spot urine protein: creatinine ratio (uPCR) or 24-h sample
analysis, is undertaken [5].
Conﬁdential enquiries into maternal deaths in the United Kingdom
report that women can develop pre-eclampsia between antenatal visits;
and reiterate the importance of blood pressure and proteinuria testing
at every opportunity [6,7]. Urine self-testing in pregnancy is widely
acceptable for conﬁrming a pregnancy through urinary beta-hcg assays
[8,9], but few data on the accuracy of self-testing for proteinuria in the
pregnant population exist [4]. An Australian study, comparing urinary
protein self-testing by 212 women in clinic, to re-testing by a single
nurse, found that self-testing was practical and easily implemented, but
did not include an independent reference standard [10]. Several other
studies describe providing pregnant women with urine dipsticks to
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periodically check for protein alongside self-monitoring blood pressure,
but have not formally evaluated test performance [11–13].
The aim of this study was to assess the accuracy of self-testing for
proteinuria during pregnancy compared to healthcare professionals
(HCPs) or automated testing with a laboratory reference standard and
to explore feasibility and acceptability in a UK context.
2. Methods
This was a mixed methods study combining test accuracy studies
and questionnaires. There were four parts comprising: 1) test accuracy
study for ‘proteinuria’ (using synthetic samples to provide a range of
protein levels) comparing assessment by pregnant women, HCPs and an
automated reader to a laboratory reference standard; 2) self-testing of
urine by pregnant women compared to testing by HCPs and a labora-
tory reference standard; 3) a questionnaire to participating women and
HCPs and 4) an online questionnaire aiming to understand women’s
experience of self-testing and opinions on its future use.
2.1. Test accuracy of urinary protein testing
Up to 50 pregnant women of any gestation and 50 HCPs from an-
tenatal maternity services were selected on a convenience basis from
hospital sites in Oxfordshire (John Radcliﬀe and Horton Hospitals, Ox)
and London (St Thomas’ Hospital, STH) between November 2015 and
April 2016. Following written informed consent, participants were
provided with simple instructions for protein testing, synthetic protein
samples and standard dipstick reagent strips (a visually read enzymatic
test) (ALBUSTIX reagent strips, SIEMENS, Surrey UK). Protein solutions
were prepared using bovine serum albumin (Sigma-Aldrich, Dorset, UK)
in 150mmol/L sodium chloride (Fresenius Kabi Ltd, Cheshire, UK).
Sodium azide was added at a concentration of 100mg/L as a bacter-
iostat. Stock solutions were produced at protein concentrations
equivalent to seven diﬀerent dipstick readings between ‘negative’ and
‘3+’ (≥500mg/dL). The level of protein in the samples was conﬁrmed
by repeated testing by urinary protein-creatinine ratio, (uPCR)
(Supplementary Table 1). Samples were tested by participating women
and HCPs using visual determination as well as using an automated
reader (Clinitek Status+Analyzer, SIEMENS, Surrey, UK) by the re-
search team. Researchers and participants were masked to the level of
protein in each sample until recruitment and testing was complete.
Samples were re-tested following the study to conﬁrm that storage and
testing had not resulted in contamination. Ethical approval was ob-
tained from the Northern Ireland Research Ethics Committee (15/NI/
0157/HSC REC-B).
2.2. Self and healthcare professional proteinuria testing compared to a PCR
reference standard
Thirty women, participating in a pilot study of blood pressure self-
monitoring in higher-risk pregnancy, attending antenatal care in
Oxfordshire additionally tested their urine for protein. (National
Institute for Health Research (NIHR) Central Research Network (CRN)
Portfolio number: 14151) They used a standard testing strip for pro-
teinuria (as above) and retained the sample, which was subsequently
(same day) tested by the midwife and then sent for laboratory analysis
(uPCR). Equivalent categories for testing were 0–14mg/dL (negative),
15–30mg/dL (trace), > 30mg/dl (1+ or more). Ethical approval was
obtained from Oxford South Central Research Ethics Committee (12/
SC/0625 REC-B).
2.3. Questionnaire
Participants in the synthetic sample testing study above completed a
short questionnaire about the potential for self-testing during preg-
nancy, included three closed statements and an open question asking
for comments (Supplementary Fig. 1).
2.4. Online survey
An online survey (March 2106) collected information on women’s
views and experiences of self-testing, including multiple-choice ques-
tions and a free text section for women to comment on the idea of self-
testing. A link to the survey was posted on the ‘Action on Pre-eclampsia’
(APEC) Facebook Forum, a UK charity and patient support group.
Ethical approval was obtained from St Georges Research Ethics
Committee (SGREC16/0005).
2.5. Statistical analysis
Data were analysed using Excel and R. Descriptive statistics were
compiled from the questionnaire and survey results for questions with
categorical answers. For proteinuria dipstick accuracy results, the er-
rors of the dipstick readings were grouped into ﬁve categories (−2,−1,
0, +1, +2), representing the diﬀerence between the reading from the
woman, the HCP and the automated reader respectively compared to
the uPCR reference standard. (e.g. +1 error where the woman’s reading
was one category above that of the uPCR). Each participant’s test per-
formance (pregnant woman, HCP, automated reader) was calculated
across all seven samples and a mean calculated per participant to obtain
sensitivity and speciﬁcity for each participant. In the case of missing
data for an individual, the sensitivity and speciﬁcity were calculated
using the available samples. In order to compare sensitivity and spe-
ciﬁcity per group, mean sensitivity and speciﬁcity were calculated,
using a threshold for a positive result of 1+ proteinuria (as errors
across this threshold were considered clinically important) [3]. False
positive and false negative rates were calculated and a logistic regres-
sion model was used to compare the diﬀerence between the three
groups (pregnant woman, HCP, automated reader). All data were in-
cluded.
2.6. Questionnaire analysis
Free text responses in the questionnaire and online survey were
analysed using a thematic approach. The qualitative data was read
multiple times by researchers (KT, LB and PM) and analysed using the
‘one sheet of paper’ (OSOP) method [15]. Themes were examined
across the whole dataset and in the context of individual responses.
3. Results
3.1. Test accuracy study
A total of 100 pregnant women and 96 HCPs performed dipstick
urine testing on the seven synthetic protein samples (Supplementary
Fig. 2 Produced using STARD reporting guidelines [14]). Of the preg-
nant women approached, 100 of 105 (95%) agreed to participate.
Participating women had a mean gestation of 31 weeks (range
9–41weeks), with 21 (21%) having had raised blood pressure during
their pregnancy. There were small numbers of missing data (three
missed samples). The HCPs who participated included 54 (56%) mid-
wives, 21 (22%) midwife support workers and 21 (22%) doctors.
Overall, the number and type of errors from pregnant women and
HCPs were similar (Table 1; Fig. 1). There were a similar proportion of
errors of potential clinical importance (Supplementary Fig. 2) (i.e. those
around 1+ threshold (Table 1) between pregnant women (10% false
negatives and 2% false positives) and HCPs (10% false negatives and
4% false positives) when compared to laboratory reference standards
whereas the automated reader had fewer false negatives (4%) but more
false positives (10%).
There was no statistically signiﬁcant diﬀerences between pregnant
women and HCPs in sensitivity, speciﬁcity (p= .45 for both), positive
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predictive value or negative predictive value (p= .58 for both); how-
ever the automated reader had higher sensitivity, lower speciﬁcity, a
lower positive predictive value and higher negative predictive value
(p= or< .001 in each case, Table 2) compared to pregnant women and
HCPs.
3.2. Self and healthcare professional proteinuria testing compared to a PCR
reference standard
All 30 women who were approached agreed to self-test urine in
conjunction with blood pressure self-monitoring. Four women (13%)
withdrew from the study (one due to pregnancy loss) before the urine
testing phase. The baseline characteristics of the participants are shown
in Supplementary Table 2. All remaining participants provided a
sample for midwife and laboratory analysis and 25/26 (96%) self-
tested. Of 25 comparisons of participant-read dipstick vs. HCPs, 22
(88%) were identical and three (12%) were discrepant, all between
negative and trace readings with no subsequent potential impact on
clinical action. Of 23 comparisons of participant-read dipsticks with
uPCR (two samples were not analysed in error), 21 (91%) were iden-
tical with two (9%) discrepant results. All were between 0–15mg/dL
(negative categories) and 15–30mg/dL (trace).
3.3. Questionnaire results
Of those who undertook the accuracy study, 99 (99%) pregnant
women and 94 (98%) HCPs also completed a questionnaire. Of women
completing the questionnaire, 95 (96%) agreed that they would be
willing to check their urine at home and 89 (90%) thought it would
make them feel more involved in their care. All were potentially happy
to share any urine testing results with their midwife, family physician
or obstetrician. There was very little discrepancy in responses between
women in Oxfordshire (Ox) and London (STH) (Fig. 2).
Most HCPs respondents indicated that they would value self-testing
by some women during their pregnancy (n=83, 88%), and thought
that proteinuria self-testing alongside blood pressure self-monitoring
would add to usual care (n= 73, 78%). However, the majority also
stated that they would always repeat urinalysis if a woman had already
tested her urine (n= 66, 69%) (Fig. 2E).
Free text responses were provided by 57 (58%) pregnant women
and 67 (71%) HCPs who completed the questionnaire, with similar
proportions across sites (Quotes in Fig. 3). Themes emerging from
analysis of these responses included reassurance from testing (women),
the potential for earlier detection (HCPs), potential for saving time
(both) and concerns about women testing (both).
Women were reassured by negative results and potentially saving
time on trips to appointments (STH34). HCPs considered that self-
Table 1
Percentages of testing at diﬀerent thresholds by pregnant women, health care professionals and automated readers. Numbers in bold represent false positive readings, ﬁgures in bold and
italics represent false negative readings deﬁned in each case as a misclassiﬁcation, which would change management.
Results are shown as a proportion of women answering to allow comparisons between groups. *each sample tested at least twice in each machine.
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testing had potential for early detection of pre-eclampsia, empowering
women and saving time and money (Ox53) (Fig. 3).
However, pregnant women and HCPs raised concerns about apti-
tude and suitability of women for testing. Whilst many women found
the dipsticks easy to use, some were worried about their ability to read
them accurately (STH 38). Several women indicated wanting access to
midwives for a second opinion (STH 30). Similarly, HCPs also raised
concerns around a woman's ability to read the dipsticks, their under-
standing of the importance of doing testing as regularly as instructed
and acting on results appropriately. Some were concerned that women
could fail to act on positive results (STH 19), while others were con-
cerned that self-testing might make women more anxious and more
likely to present at assessment units, increasing demand on services (Ox
47). Consequently some felt self-testing was only suitable for certain
subgroups of women (STH 31) (Fig. 3).
3.4. Online survey
Two hundred women completed the online survey, (characteristics
in Supplementary Table 3 and free text quotes Fig. 4) with the majority
of respondents (77%, n=152) having experienced a hypertensive
disorder of pregnancy. One ﬁfth of women (20%; n= 39) had pre-
viously undertaken proteinuria self-testing (Supplementary Table 4)
and most of these had found the dipsticks easy to read (87%, n=34).
Women reported positive experiences of self-testing, with all agreeing
that it helped them feel involved in their care, and only 10% (n=4)
reporting increased anxiety levels due to proteinuria self-testing.
Of 17 respondents who had previously tested, most indicated that
prior experiences of pre-eclampsia motivated them to test their own
urine and key themes were of reassurance, saving time and empower-
ment. Many discussed anxiety due to previous experiences, but found
reassurance from negative results in this setting (PT1). One woman
found self-testing useful because she perceived that it was less inﬂu-
enced by her immediate anxiety level compared to blood pressure
readings (PT2). Three women said that they were reassured by self-
monitoring between scheduled antenatal appointments, and that this
prevented unnecessary trips to the hospital. One woman commented on
the value of a positive proteinuria result (PT3) (Fig. 4).
Of those women who had not experienced self-testing for protei-
nuria (81%, n= 161), the majority (99%, n=159) said they would be
willing to check their own urine for protein after training
(Supplementary Table 5). The majority (97%, n= 155) said that self-
testing would help them feel more involved in their pregnancy care.
Conversely, 26 women (17%) agreed or strongly agreed with the
statement that self-testing would increase their anxiety during
Fig. 1. Protein testing results by samples and categories.
Test results are shown for 100 pregnant women (PW), 96
healthcare professionals (HCPs) and three automated
readers. The errors of the results were grouped into ﬁve
categories types (−2, −1, 0, 1, 2). The ‘0’ results show no
error, the type 1 error are outcomes with 1 category above
the correct answers. Check shading indicates clinically im-
portant false positive results and spotted shading indicates
clinically important false negative results.
Table 2
Group mean test accuracy of results by pregnant women, healthcare professionals and
automated readers compared to uPCR (laboratory reference standard).
Pregnant
women
Healthcare
professional
Automated
readers
Sensitivity 0.81
(0.78–0.85)
0.83 (0.79–0.86) 0.94 (0.91–0.97)
Speciﬁcity 0.93
(0.91–0.95)
0.92 (0.90–0.94) 0.78 (0.69–0.85)
Positive predictive
value
0.94
(0.90–0.96)
0.94 (0.91–0.95) 0.85 (0.79–0.90)
Negative predictive
value
0.79
(0.75–0.83)
0.80 (0.76–0.84) 0.91 (0.87–0.95)
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pregnancy (Supplementary Table 5).
Women who had not tested their own urine had similar themes of
reassurance and empowerment to those that had self-tested, with ad-
ditional issues raised of training and HCPs’ attitudes. Reassurance ap-
peared particularly important in those who had previous experience of
pre-eclampsia or hypertension (NT1) Urine testing could reduce rather
than increase anxiety (NT2): Adequate training, explanation and clear
instructions could also reduce any anxiety they felt (NT3). The women
emphasised that it was important that HCPs were receptive to the re-
sults (NT4) (Fig. 4).
4. Discussion
4.1. Main ﬁndings
This study has shown that pregnant women and HCPs were able to
test for proteinuria over a range of protein concentrations with similar
levels of accuracy. As with previous research, testing by women and
HCPs was less sensitive but more speciﬁc than automated testing using
a reference standard of laboratory uPCR. Overall self-testing was ac-
ceptable to both pregnant women and HCPs both theoretically and
alongside blood pressure self-monitoring. Self-testing was perceived as
providing reassurance and convenience for women, particularly those
with previous experience of hypertensive disease in pregnancy, though
there were some concerns as to whether HCPs would always trust the
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results provided by pregnant women. Women felt that support from
their HCPs would be important, perhaps reﬂecting the reticence of
professionals to act on women’s own results.
4.2. Strengths and limitations
This mixed methods study has included a relatively large number of
women and HCPs who tested samples over a range of protein con-
centrations both on synthetic and real urine, providing comprehensive
data on test accuracy. Use of synthetic urine samples ensured that
suﬃcient numbers of positive samples were tested, and whilst the
numbers testing their own urine were relatively small (n= 26) and for
a limited period they provided similar results and were representative
of women who might be asked to undertake such testing. This suggests
that it is unlikely that the accuracy of testing would be altered in a
clinical vs home setting, though the experience may be. Previous pilot
work of self-testing of blood pressure in pregnancy completed by this
group has indicated that women found blood pressure monitoring ac-
ceptable and reassuring. Women who completed proteinuria testing in
the home environment were positive about the experience but further
work on the experience of regular self-testing through pregnancy is
required.
Questionnaire and online survey data gathered views from a large
number of participants including currently pregnant women, those with
and without experience of self-testing, women with both hypertensive
and normotensive pregnancies and a variety of HCPs providing a range
of experiences and opinions. The majority of online survey participants
had experienced hypertensive disorders of pregnancy, and therefore
those most likely to be considered for additional home testing. The
survey provided both quantitative and qualitative data providing an in-
depth understanding of views and experiences. The similarity between
the questionnaire results of pregnant women and the online survey
ﬁndings suggest broad acceptability and appeal of self-testing.
Some selection bias from the online survey is possible as re-
spondents were limited to internet users; however, most of the target
population will be web connected [16]. By engaging with the charity
APEC and responding to the online survey, the participants were likely
to be individuals with previous experience, who had sought extra in-
formation and support, and may therefore be more motivated to adopt
health behaviours such as proteinuria self-testing.
4.3. Comparison with previous work
There are surprisingly few data on proteinuria self-testing in the
pregnant population. A 2002 Australian study showed that women in-
terpreting results in clinic had a tendency to overestimate proteinuria
Quotes from free text responses 
“Being high risk myself I feel it would give peace of mind and less stress of running to the GP constantly to 
be able to test your urine at home” (STH 34).
“I think that self-monitoring is very useful to save health professionals ?me and the women’s ?me in going 
to appointments. I believe it is also empowering for the women.” (Ox 53)
“The tes?ng procedure is simple, although the results are some?mes hard to interpret if they are ‘in 
between’ colours” (STH 38).
“Some mums might not feel capable doing it if they are not trained and would want someone who has 
training to check it to be sure that they are ge?ng the right answer” (STH 30).
“I'd worry about women forge?ng to do it or saying they would and making up normal results to avoid 
being high risk.” (STH 19).
“It could cause unnecessary admi?ance to MAU [Maternity Assessment Unit] if women not trained 
appropriately.” (Ox 47).   
“It would depend on the women and their understanding of the importance of this tes?ng.” (STH 31). 
Fig. 3. Quotes from free text responses gained from the
accuracy study.
Quotes from the free text sec?on in the online survey 
PT1 “I found it hugely reassuring to be able to check this myself at home, it was empowering and took 
away the anxiety around appointments.”
PT2 “Also knowing how nervous I was about BP (therefore how it can ?uctuate some?mes with stress 
levels) I also wanted something to measure that couldn't be in?uenced by anxiety or stress.”
PT3 “The dips?cks gave me the con?dence to go back in [to the hospital], which was the right decision 
to make.”
NT1 “Having got severe PET and HELLP a few hours a?er birth with my ?rstborn I know that if I have 
another I would be really anxious about it occurring in pregnancy and would feel worried in between 
antenatal check-ups so it would reassure me.” 
NT2 “During pregnancy a lot felt out of my control and wai?ng between midwife appointments 
some?mes le? me anxious. Self-tes?ng would make me feel like I could do something myself to take 
away some anxiety”.
NT3 “I also agree that it may cause more anxiety for some if the reading is not clear cut, as long as 
training and reference points are clear for mothers I do believe this would be bene?cial overall.”
NT3 “GP surgeries need to be be?er briefed as well on this, otherwise pa?ents could self-test and s?ll 
the doctor ignores the signs.” 
Fig. 4. Quotes from the free text section in the online
survey.
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compared to the midwife performing the same test; the authors sug-
gested that self-testing of urine during pregnancy could be easily im-
plemented at antenatal visits [10]. More recently, large screening stu-
dies undertaken within the general non-pregnant population for early
detection of renal disease found that self-testing improves the chances
for early diagnosis and therapy, though participants tended to report
false positives for proteinuria [17,18].
There is heterogeneity in the reported sensitivity and speciﬁcity of
testing with reagent strips within the literature across patient and staﬀ
groups, and limited data from studies in pregnancy. Bell et al. used ﬁve
albumin samples to look at the accuracy of testing and reported a high
false positive rate for the two non-proteinuric samples (nursing aux-
iliaries; 40% and 55% and midwives; 5% and 30%). For the three po-
sitive samples both groups recorded false negative rates of between
10–45% [19]. While automated readers had higher sensitivity, they also
produced a lower speciﬁcity, i.e. yielding more false positive results
that may lead to unnecessary anxiety and additional appointments and
testing for some women [20,21]. These studies compare to false posi-
tive rates of only 2–4% in our study; the majority of false negative re-
sults related to diﬀerences between negative and trace amounts of
proteinuria, and would therefore not have changed clinical action.
There are no published studies to date on user experiences of pro-
teinuria self-testing. Most of the literature on patient views and ex-
periences of self-monitoring come from studies of blood pressure self-
monitoring outside of pregnancy, which have generally found similarly
positive views to results reported here. A feasibility study done in low-
risk pregnant women showed a preference for blood pressure self-
monitoring with a reduced schedule of antenatal visits, and no change
in anxiety levels [22]. Literature on blood pressure self-monitoring
outside pregnancy indicates patients are conﬁdent at self-monitoring
and report high levels of satisfaction and feelings of involvement,
control, and support for their health [23,24]. In the current study si-
milar ﬁndings for self-testing of urine are reported; women whose
readings were used by HCPs felt valued and involved in their own care
and reported positive experiences. Combined self-testing of blood
pressure and urine could allow triggers for action based on home
readings to mirror clinical diagnostic pathways for pre-eclampsia, could
increase women’s conﬁdence in ﬁndings, improve self-involvement in
antenatal care and reduce additional screening visits thereby providing
a cost-eﬀective intervention [25].
4.4. Implications for future research and clinical practice
The results of this study are an important ﬁrst step in considering
the potential for self-monitoring for proteinuria in pregnancy. This in-
expensive, simple and rapid test could improve detection of pre-
eclampsia, a potentially serious condition, and be used to reduce ad-
ditional appointments required by some pregnant women (thereby al-
leviating burden on women and healthcare resources). Self-testing was
acceptable and well received in a population of women who were at
increased risk of pre-eclampsia. Participants were willing and able to
test for proteinuria alongside blood pressure self-monitoring during
pregnancy and self-testing appears to be as accurate as testing by HCPs.
A full evaluation of the impact on detection rates of proteinuria and pre-
eclampsia, cost eﬀectiveness, pregnancy outcomes and women’s ex-
periences of regularly completing self-testing is needed before con-
sidering adopting self-monitoring more widely during pregnancy.
4.5. Intended population
This pilot work conﬁrms that women at higher risk of pre-eclampsia
are willing and able to complete this testing. The most suitable popu-
lation for regular proteinuria self-testing may be pregnant women who
have developed hypertension or those at high risk within the second
half of pregnancy when pre-eclampsia is most likely to develop.
4.6. Barriers
While testing for urinary protein and monitoring of blood pressure
are known to be of value during pregnancy, self-testing is unlikely to be
suitable for all women. In addition, HCPs will need evidence to be
convinced about the beneﬁts of self-testing and require clear pathways
to follow alongside current care.
5. Conclusion
This research suggests that self-testing of proteinuria is feasible,
acceptable and potentially advantageous for both pregnant women and
HCPs. If shown to be suﬃciently accurate when tested at scale and is
cost eﬀective, proteinuria self-testing has the potential to be a valuable
method of screening for pre-eclampsia in pregnancy, and may result in
earlier diagnosis of this condition than current practice.
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